Intercept

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

bismuth subnitrate; chlorhexidine (free acid)

Available from:

Elanco New Zealand

INN (International Name):

bismuth subnitrate, chlorhexidine

Composition:

bismuth subnitrate 650 g/kg; chlorhexidine (free acid) 5 g/kg

Therapeutic area:

Antimicrobial

Authorization status:

ACVM Registered

Authorization date:

2010-11-17

Summary of Product characteristics

Injector
Date of issue: 15 Feb 2017
_The information above this line is not included in the label _
[Bayer logo]
DANGER
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
INTERCEPT
™
INTERNAL TEATSEALANT FOR COWS AND HEIFERS
ACTIVE CONSTITUENTS
Each 4 g contains: Bismuth subnitrate 2.6 g and Chlorhexidine 20 mg
(0.5% w/w) in an oily base
DIRECTIONS FOR USE
See carton or bin label
WITHHOLDING PERIODS
MILK: 8 MILKINGS
MEAT: NIL
ACVM No. A10540
BAYER NEW ZEALAND LIMITED
3 Argus Place, Hillcrest, Auckland 0627, New Zealand
Customer Info Line: 0800 927 733
Batch No.:
Exp.:
Bin Label (main panel)
Date of issue: 15 Feb 2017
_The information above this line is not included in the label _
DANGER
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
INTERCEPT
™
INTERNAL TEATSEALANT FOR PREVENTION OF MASTITIS IN COWS AND HEIFERS
For the prevention of mastitis in cows after drying off and
peri-calving mastitis in maiden
heifers.
ACTIVE CONSTITUENTS
Each 4 g single dose injector contains Bismuth subnitrate 2.6 g and
Chlorhexidine 20 mg (0.5% w/w)
in an oily base
300 INJECTORS
Bin Label (left panel)
Date of issue: 15 Feb 2017
_The information above this line is not included in the label _
INDICATIONS
For the prevention of mastitis in non-lactating (dry period) dairy
cows and heifers, with low
individual somatic cell count (First lactation < 120,000 cells/mL;
subsequent lactation < 150,000
cells/mL) at drying off. Also for pre-calving administration in maiden
heifers for the prevention of
mastitis.
CONTRAINDICATIONS
Not for use in lactating cows – administer after final milking.
Not recommended for use without appropriate antibiotic Dry Cow Therapy
in animals with a high
somatic cell count (
First lactation
> 120,000 cells/mL;
subsequent lactation
> 150,000 cells/mL) at
drying off, as this may be indicative of existing intramammary
infection.
DOSAGE
COWS/HEIFERS: Infuse the contents of 1 syringe per quarter after the
final milking of lactation.
MAIDEN HE